Norwood, MA (PRWEB) August 06, 2012
Infinata Inc., part of the Financial Times Group of companies, has developed an intuitive and interactive user interface as the basis for its leading global biopharmaceutical solutions, BioPharm Insight™ and BioPharm Clinical™. Interested individuals may sign up in August for a free trial to take advantage of all the new features such as a personal Workspace, expanded data analytics, interactive graphs and more.
Both cloud-based products have been completely redesigned from the ground-up to provide the optimal user experience while enabling them to quickly find the precise information they are looking for. Highlights of the new platform include:
BioPharm Insight (free trial)
BioPharm Clinical (free trial)
“We developed this new platform closely with our valued clients to help them do their jobs more efficiently than ever,” said Ruth McHenry, Managing Director at Infinata. “Whether a CRO in China is searching for Phase III trial management opportunities or a clinical operations director in the United States is trying to identify trustworthy European investigators for a global asthma study, customers will spend less time searching for critical strategic information and more time using it.”
About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides clients with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit biopharminsight.com.
About BioPharm Clinical
BioPharm Clinical is an exclusive support solution for clinical operations professions, providing real-time trial analytics and the most comprehensive database of sites and investigators. Clients benefit from proprietary calculations tailored to their particular trial requirements, detailed milestone timelines and more as they make critical study feasibility assessments and evaluate investigators for their global programs. Learn more at biopharmclinical.com.
About Infinata, Inc.
Featuring a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services, Infinata provides personalized technology solutions to turn information into insight. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit infinata.com.